Intra Cellular Therapies | 流動負債



Current Liabilities 変化する 日付
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
ALKERMES USD 465.2M 11.5M 2024-12
Biogen USD 5.53B 103.8M 2024-12
Bristol-Myers Squibb USD 23.77B 1.14B 2024-12
Cytokinetics USD 179.67M 69.86M 2024-12
Gilead Sciences USD 12B 279M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
J&J USD 50.32B 1.44B 2024-12
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12
Prothena USD 48.5M 2.08M 2024-12
RedHill Biopharma USD 21.23M 0 2024-06
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
United Therapeutics USD 738.1M 135.3M 2024-12



Intra Cellular Therapies 流動負債 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2025.